The frameworks for such kits for use in clinical applications have been developed in collaboration between governments and industry stakeholders. So far, international research efforts have accelerated in recent months in order to develop such kits that can be moved from bench to bedside for a variety of infectious diseases with enormous promise, including COVID. The constant genetic alterations seen in infections have made evaluating the practical relevance of fast medical diagnostic tests difficult.
The market for Rapid Medical Diagnostic Kits is expected to grow in the coming years, thanks to rising demand for point-of-care (POC) diagnostics, a high influx of portable rapid testing devices on the market, an increase in the number of infectious disease cases, and an expanding geriatric population base. The European Centre for Disease Prevention and Control, the World Health Organization, and the Centers for Disease Control and Prevention are all actively involved in mapping data on the incidence and prevalence of infectious diseases in order to systematically control the disease.
Read More@ https://bit.ly/3HIds5Q
